While enzymatic DPP-4 may be more closely related to obesity-associated inflammation and glucose regulation, soluble DPP-4 may have a distinct role that is not associated with inflammation
Key Findings from a Large-Scale Study A large real-world study using the TriNetX Analytics Network (20102022) analyzed outcomes in 5,291 PV patients treated with GLP-1 RAs compared with 79,027 untreated patients
The alternative many people prefer is taking drops immediately upon waking, doing their morning routine during the hold and fasting period, then enjoying coffee after the 30-minute window
et al, Hyperhomocysteinemia in myelodysplastic syndromes: specific association with autoimmunity and cardiovascular disease
While possible, maintaining results after stopping GLP-1 therapy is challenging and requires intensive lifestyle modifications including 200-300 minutes of weekly exercise, consistent dietary changes, regular self-monitoring, and often ongoing behavioral support
Novo Nordisk recommends asking these questions to an insurance company that does not cover Wegovy: Are there any other options to get Wegovy covered by insurance